TARA Overview
Upcoming Projects (TARA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (TARA)
-
A Third Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 11, 2025 at 08:15 AM EDT -
A Second Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 10, 2025 at 05:00 PM EDT -
Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 09, 2025 at 12:00 PM EDT -
A Third Look: Discussing the positive results from the ongoing Phase 2 ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC).
Ticker: TARA
Executed On: Feb 10, 2025 at 11:00 AM EST -
A Second Look: Discussing the positive results from the ongoing Phase 2 ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC).
Ticker: TARA
Executed On: Jan 13, 2025 at 12:00 PM EST -
Discussing the positive results from the ongoing Phase 2 ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC).
Ticker: TARA
Executed On: Jan 13, 2025 at 10:00 AM EST
Upcoming & Overdue Catalysts (TARA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (TARA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
